<code id='8D3A80BCAC'></code><style id='8D3A80BCAC'></style>
    • <acronym id='8D3A80BCAC'></acronym>
      <center id='8D3A80BCAC'><center id='8D3A80BCAC'><tfoot id='8D3A80BCAC'></tfoot></center><abbr id='8D3A80BCAC'><dir id='8D3A80BCAC'><tfoot id='8D3A80BCAC'></tfoot><noframes id='8D3A80BCAC'>

    • <optgroup id='8D3A80BCAC'><strike id='8D3A80BCAC'><sup id='8D3A80BCAC'></sup></strike><code id='8D3A80BCAC'></code></optgroup>
        1. <b id='8D3A80BCAC'><label id='8D3A80BCAC'><select id='8D3A80BCAC'><dt id='8D3A80BCAC'><span id='8D3A80BCAC'></span></dt></select></label></b><u id='8D3A80BCAC'></u>
          <i id='8D3A80BCAC'><strike id='8D3A80BCAC'><tt id='8D3A80BCAC'><pre id='8D3A80BCAC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:9247
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Novel spinal cord stimulator treats paralysis without surgery
          Novel spinal cord stimulator treats paralysis without surgery

          CourtesyOnwardMedicalAfterhisspinalcordinjuryin2014,SherownCampbellworkedhardtoregainasmuchbodilyfun

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          AltruBio raises $225 million to develop ulcerative colitis drug

          Micrographofchronicactiveulcerativecolitisinabiopsyspecimen.WikimediaCommonsCheckpointinhibitors,dru